Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 2,600 | 2,359 | 2,384 | 0 | 2,880 |
| Cost of Goods | 1,238 | 1,192 | 1,138 | N/A | 1,174 |
| Gross Profit | 1,362 | 1,167 | 1,246 | N/A | 1,706 |
| Operating Expenses | 2,362 | -1,000 | 2,098 | 0 | 2,428 |
| Operating Income | -766 | -873 | -714 | N/A | -548 |
| Other Income | 25 | 873 | 1 | 0 | 3 |
| Pre-tax Income | -741 | 0 | -713 | 0 | -545 |
| Net Income Continuous | -741 | N/A | -713 | N/A | -545 |
| Net Income | $-745 | $N/A | $-713 | $N/A | $-545 |
| EPS Basic Total Ops | -0.10 | -0.10 | -0.10 | N/A | -0.10 |
| EPS Basic Continuous Ops | -0.06 | N/A | -0.10 | N/A | -0.08 |
| EPS Diluted Total Ops | -0.10 | -0.10 | -0.10 | N/A | -0.10 |
| EPS Diluted Continuous Ops | -0.06 | N/A | -0.10 | N/A | -0.08 |
| EBITDA(a) | $-632 | $2,394 | $-714 | $N/A | $-413 |